Skip to Content
Merck
  • Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

The Journal of infectious diseases (2007-09-01)
Robert K Ernst, Samuel M Moskowitz, Julia C Emerson, Gretchen M Kraig, Kristin N Adams, Megan D Harvey, Bonnie Ramsey, David P Speert, Jane L Burns, Samuel I Miller
ABSTRACT

Three structural features of lipid A (addition of palmitate [C16 fatty acid], addition of aminoarabinose [positively charged amino sugar residue], and retention of 3-hydroxydecanoate [3-OH C10 fatty acid]) were determined for Pseudomonas aeruginosa isolates from patients with cystic fibrosis (CF; n=86), from the environment (n=13), and from patients with other conditions (n=14). Among P. aeruginosa CF isolates, 100% had lipid A with palmitate, 24.6% with aminoarabinose, and 33.3% retained 3-hydroxydecanoate. None of the isolates from the environment or from patients with other conditions displayed these modifications. These results indicate that unique lipid A modifications occur in clinical P. aeruginosa CF isolates.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-3-Hydroxydecanoic acid, ≥98%